Targeting α-synuclein for treatment of Parkinson's disease: Mechanistic and therapeutic considerations.
The Lancet Neurology.
Times cited: 163
Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant sod1 motor neurons.
Journal of Neuroscience.
Times cited: 74
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease.
Times cited: 339
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.
Times cited: 594